Learning Center

GLP-1 Coverage Set to Expand

Current rules limit obesity-drug coverage, but temporary demonstrations aim to widen GLP-1 access for eligible public-program enrollees while lowering medication costs overall. Federal drug-benefit enrollees may access select obesity GLP-1s from Early-Q3 2026 through 2027, with a $50 monthly copay Read more